Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas.

Vanessa DrendelBianca HeckelmannChristoph SchellLucas KookMartin L BiniossekMartin WernerCordula A JilgOliver Schilling

Published in: Clinical proteomics (2018)

We present one of the first differential proteome profiling studies on ROs and chRCCs and highlight differential abundance of LAMP1 and ITGAV in these renal tumors.

Keyphrases

single cell
dna damage
cell death
renal cell carcinoma
cell therapy
microbial community
antibiotic resistance genes
case control
wastewater treatment
anaerobic digestion